Stock Price Prediction

BDX

0.000

0.000(0.000%)

BDX Price Prediction Next Week

Based on the provided data and recent market activity, here's a comprehensive analysis for BDX's price movement in the next trading week:

Technical Analysis

The technical indicators show:

RSI at 69.91 indicates approaching overbought territory but still has room to run
MACD at 3.75 shows positive momentum
Price is trading above both SMA-20 (233.17) and SMA-200 (231.80), confirming bullish trend

Recent Price Action & Volume Analysis

Current price: $243.45 (as of Jan 24, 2025)
Trading volume has increased with price movement, showing strong buying interest
The stock has formed a strong support level around $227.17

News Sentiment & Fundamental Catalysts

Recent collaboration announcement with Biosero to enhance drug discovery automation capabilities
Strong historical performance in late January, with BDX showing consistent gains of 1.56% during the final week
The company's pharma systems business is expected to accelerate from GLP-1s growth and emerging on-body products

Price Target Analysis Based on the technical and fundamental factors, here are the price targets for next week:

Support level: $238.84
Resistance level: $248.06
Expected trading range: +/-1.89% from current price

Trading Recommendation BUY with the following rationale:

Strong technical setup with price above key moving averages
Positive fundamental catalysts with new partnerships
Seasonal strength in late January
No major resistance above current price until $248 level

Set stop-loss at $235.08 (-3.44%) to manage risk

Based on the provided data and recent market activity, here's a comprehensive analysis for BDX's price movement in the next trading week:

Technical Analysis

The technical indicators show:

RSI at 69.91 indicates approaching overbought territory but still has room to run
MACD at 3.75 shows positive momentum
Price is trading above both SMA-20 (233.17) and SMA-200 (231.80), confirming bullish trend

Recent Price Action & Volume Analysis

Current price: $243.45 (as of Jan 24, 2025)
Trading volume has increased with price movement, showing strong buying interest
The stock has formed a strong support level around $227.17

News Sentiment & Fundamental Catalysts

Recent collaboration announcement with Biosero to enhance drug discovery automation capabilities
Strong historical performance in late January, with BDX showing consistent gains of 1.56% during the final week
The company's pharma systems business is expected to accelerate from GLP-1s growth and emerging on-body products

Price Target Analysis Based on the technical and fundamental factors, here are the price targets for next week:

Support level: $238.84
Resistance level: $248.06
Expected trading range: +/-1.89% from current price

Trading Recommendation BUY with the following rationale:

Strong technical setup with price above key moving averages
Positive fundamental catalysts with new partnerships
Seasonal strength in late January
No major resistance above current price until $248 level

Set stop-loss at $235.08 (-3.44%) to manage risk

BDX Similar Chart Price Prediction

The price of BDX is predicted to go up 3.38%, based on the high correlation periods with SWBI. The similarity of these two price pattern on the periods is 97.77%.

BDX

SWBI

Up: 3.38%Similarity: 97.77%

BDX Revenue Forecast

BDX EPS Forecast

BDX FAQs

What is revenue forecast for next quarter？

What is eps forecast for next quarter？

BDX VS S&P500

The pharmaceutical business is the star of BD's portfolio. We expect robust growth to continue driven by demand for injectables.

BD reinvested its testing windfall into R&D in its key areas, which will likely lead to the elevated growth (relative to its historic levels) going forward.

We estimate Alaris sales will recover to close to pre-recall levels by 2025.

Ask Intellectia about BDX

BDX Analyst's Forecast

Joanna Wiensch

Citigroup

Hold → Strong Buy

Price Target

$255 → $275

Upside

+13.82%